Hayat Pharmaceutical Industries Co. PLC announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was JOD 5.003 million compared to JOD 4.732 million a year ago. Net income was JOD 895,515 compared to JOD 775,700 a year ago. Basic earnings per share from continuing operations was JOD 0.09 compared to JOD 0.08 a year ago. For the nine months, sales was JOD 12.660 million compared to JOD 11.481 million a year ago. Net income was JOD 2.535 million compared to JOD 2.139 million a year ago. Basic earnings per share from continuing operations was JOD 0.27 compared to JOD 0.23 a year ago.